| Page 2 of 2 < |
Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk
|
Discussion Policy
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
|
"Just as having peripheral vascular disease is associated with an increased risk of cardiovascular disease through common risk factors, having AMD is associated with an increased risk of cardiovascular disease and mortality," Fonarow said.
"Patients and physicians should recognize that patients diagnosed with AMD are more likely to have underlying cardiovascular disease and subsequent events and take appropriate steps to lower that risk though lifestyle changes and cardiovascular protective therapies," Fonarow advised.
In another report in the same issue of the journal, British researchers concluded that genes that control the production of chemicals involved in inflammation may play a significant role in AMD.
One gene variation associated with the gene that produces an inflammatory chemical called interleukin 8, was significantly more common among people with AMD, the researchers found. This gene variant has been previously linked with inflammatory diseases and cancer.
If these findings hold up, the researchers think it could lead to genetic screening for AMD and possibly the development of medications to treat the disease.
More information
For more on AMD, visit the U.S. National Eye Institute.
SOURCES: Paul Mitchell, M.D., Centre for Vision Research, Department of Ophthalmology, University of Sydney, Australia; Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Feb. 28, 2008,British Journal of Ophthalmology



